TEST AND PRICE LIST FOR NEXT GENERATION SEQUENCING

Size: px
Start display at page:

Download "TEST AND PRICE LIST FOR NEXT GENERATION SEQUENCING"

Transcription

1 AIP ALK APC Mutation Detection Techniques Ai Saple Type TAT ATM BAP1 BLM BMPR1A BRCA1 BRCA2 BRIP1 BUB1B CDC73 CDH1 CDK4 CDKN1C CDKN2A CEBPA CEP57 CHEK2 CYLD DDB2 DICER1 DIS3L2 EGFR EPCAM ERCC2 ERCC3 ERCC4 ERCC5 EXT1 EXT2 TEST AND PRICE LIST FOR NEXT GENERATION SEQUENCING Price ( Euro) Producer

2 EZH2 FANCA FANCB FANCC FANCD2 FANCE FANCF FANCG FANCI FANCL FANCM FH FLCN GATA2 GPC3 HNF1A HRAS KIT MAX MEN1 MET MLH1 MSH2 MSH6 MUTYH NBN NF1 NF2 NSD1 PALB2 PHOX2B PMS1 PMS2 PRF1 PRKAR1A

3 PTCH1 PTEN RAD51C RAD51D RB1 RECQL4 RET RHBDF2 RUNX1 SBDS SDHAF2 SDHB SDHC SDHD SLX4 SMAD4 SMARCB1 STK11 SUFU TMEM127 TP53 TSC1 TSC2 VHL WRN WT1 XPA XPC Lung Panel EGFR, KRAS, EML4ALK,AKT1, MET, ALK, NRAS BRAF, PIK3CA, CTNNB1 PTEN, MAP2K1, P53

4 Colon Panel KRAS, BRAF, AKT1, NRAS, APC, PIK3CA CTNNB1, PTEN, EGFR SRC, FBXW7, P53, MET Melanoa Panel BRAF, KIT, BRAF, MAP2K1, GNA11 NRAS, GNAQ, PIK3CA KIT, PTEN, KRAS Gastric Panel (GIST) KIT, PDGFRA,AKT1, PIK3CA FGFR2, P53 Ovarian Panel AKT1, PTEN ERBB2, P53 BRCA MASTR Dx HNPCC MASTR FAP MASTR CFTR MASTR v2 CFTR MAQ CFTR HP MARFAN MASTR FMF MASTR v2 DMD MASTR MODY MASTR ADH MASTR HCM MASTR HNF4A GCK HNF4A HNF1A HNF4A PDK1 HNF4A 15 days days days 1200 Tugen Tugen Tugen Tugen

5 HNF1B HNF4A FMF Gene Mutations Tugen Tugen

Next-generation sequencing can replace Sanger sequencing in clinical diagnostics.

Next-generation sequencing can replace Sanger sequencing in clinical diagnostics. Next-generation sequencing can replace Sanger sequencing in clinical diagnostics. Birgit Sikkema-Raddatz Department of Genetics, University Medical Center Groningen The Netherlands Groningen GRONINGEN

More information

La diagnostica molecolare nelle neoplasie colo-rettali. A do Scarpa. U iversita di Vero a

La diagnostica molecolare nelle neoplasie colo-rettali. A do Scarpa. U iversita di Vero a La diagnostica molecolare nelle neoplasie colo-rettali C-NET A do Scarpa e Dipartime to Pato ogia e U iversita di Vero a La stessa malattia puo avere diverse patogenesi cucchiaio moneta forchetta Gastrointestinal

More information

patient guide CancerNext TM - A Genetic Test for Hereditary Cancer

patient guide CancerNext TM - A Genetic Test for Hereditary Cancer patient guide CancerNext TM - A Genetic Test for Hereditary Cancer What is hereditary cancer? Cancer affects many people in the U.S. more than 1.6 million people are estimated to be diagnosed with cancer

More information

Nuovi Scenari in Oncologia. G. Zoppoli X-Files in Nutrizione Clinica e Artificiale, 08/06/2012

Nuovi Scenari in Oncologia. G. Zoppoli X-Files in Nutrizione Clinica e Artificiale, 08/06/2012 Nuovi Scenari in Oncologia G. Zoppoli X-Files in Nutrizione Clinica e Artificiale, 08/06/2012 WHAT is cancer? «Cancer is a genetic disease of the somatic cell» [B. Vogelstein] Ten years ago Now [Cell.

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Genetic Cancer Susceptibility Panels Using Next Generation Sequencing File Name: Origination: Last CAP Review: Next CAP Review: Last Review: genetic_cancer_susceptibility_panels_using_next_generation_sequencing

More information

HEREDITARY CANCER GENE PANEL DG 2.3.x

HEREDITARY CANCER GENE PANEL DG 2.3.x HEREDITARY CANCER GENE PANEL DG 2.3.x Gene Median % covered % covered Associated Phenotype description and OMIM ID coverage >10x >20x ALK 99,5 100% 98% {Neuroblastoma, susceptibility to, 3}, 613014 APC

More information

BRCAplus: A Genetic Test for Hereditary Breast Cancer

BRCAplus: A Genetic Test for Hereditary Breast Cancer BRCAplus: A Genetic Test for Hereditary Breast Cancer Developed in collaboration with Fox Chase Cancer Center and the Arcadia University Genetic Counseling Program. Causes of Hereditary Breast Cancer Familial,

More information

A Patient s Guide to Hereditary Cancer. Is Hereditary Cancer Testing Right for You?

A Patient s Guide to Hereditary Cancer. Is Hereditary Cancer Testing Right for You? A Patient s Guide to Hereditary Cancer Is Hereditary Cancer Testing Right for You? What is Hereditary Cancer? Most cancers occur in people who do not have a strong family history of that cancer. This is

More information

CancerTREATMENT NGS+ NSCLC Summary Report Page 1 of 7 PATIENT SPECIMEN PHYSICIAN

CancerTREATMENT NGS+ NSCLC Summary Report Page 1 of 7 PATIENT SPECIMEN PHYSICIAN Page 1 of 7 POSITIVE TEST RESULTS Biomarker Result DETECTED NEGATIVE TEST RESULTS FDA Approved Therapies Targeting Molecular Pathway TEST DESCRIPTION: CancerTREATMENT NGS+ uses Next Generation Sequencing

More information

Launching a Cancer Genetic Laboratory to Enhance Diagnosis and Treatment

Launching a Cancer Genetic Laboratory to Enhance Diagnosis and Treatment Launching a Cancer Genetic Laboratory to Enhance Diagnosis and Treatment Arthur L. Beaudet, M.D. Department of Molecular and Human Genetics Baylor College of Medicine ORIGIN AND PRECEDENT Decades of experience

More information

Médecine de précision médecine personnalisée en Oncologie. Fabien Calvo, Directeur Recherche et Innovation, INCa, Directeur ITMO Cancer, AVIESAN

Médecine de précision médecine personnalisée en Oncologie. Fabien Calvo, Directeur Recherche et Innovation, INCa, Directeur ITMO Cancer, AVIESAN Médecine de précision médecine personnalisée en Oncologie Fabien Calvo, Directeur Recherche et Innovation, INCa, Directeur ITMO Cancer, AVIESAN Successful targeted drug development Rapid identification

More information

Test Information Sheet

Test Information Sheet Test Information Sheet GeneDx 207 Perry Parkway Gaithersburg, MD 20877 Phone: 888-729-1206 Fax: 301-710-6594 E-mail: wecare@genedx.com www.genedx.com/oncology OncoGene Dx: High/Moderate Risk Panel Sequence

More information

1199 SEIU Benefit Funds Laboratory Management Program PRIOR AUTHORIZATION CODE LIST FOR OUTPATIENT MOLECULAR AND GENOMIC LABORATORY TESTS

1199 SEIU Benefit Funds Laboratory Management Program PRIOR AUTHORIZATION CODE LIST FOR OUTPATIENT MOLECULAR AND GENOMIC LABORATORY TESTS 1199 SEIU Benefit Funds Laboratory Management Program PRIOR AUTHORIZATION CODE LIST FOR OUTPATIENT MOLECULAR AND GENOMIC LABORATORY TESTS Effective January 1, 2016 Administered by evicore healthcare Refer

More information

Section: Genetic Testing Last Reviewed Date: October 2015. Policy No: 73 Effective Date: November 1, 2015

Section: Genetic Testing Last Reviewed Date: October 2015. Policy No: 73 Effective Date: November 1, 2015 Medical Policy Manual Topic: Genetic Cancer Susceptibility Panels Using Next Generation Sequencing Date of Origin: July 2014 Section: Genetic Testing Last Reviewed Date: October 2015 Policy No: 73 Effective

More information

Hereditary Breast Cancer Panels. High Risk Hereditary Breast Cancer Panel Hereditary Breast/Ovarian/Endometrial Cancer Panel

Hereditary Breast Cancer Panels. High Risk Hereditary Breast Cancer Panel Hereditary Breast/Ovarian/Endometrial Cancer Panel P A T I E N T G U I D E Hereditary Breast Cancer Panels High Risk Hereditary Breast Cancer Panel Hereditary Breast/Ovarian/Endometrial Cancer Panel B a y l o r M i r a c a G e n e t i c s L a b o r a t

More information

NEIGE. diagnosis In oncogenetics. Nicolas Sévenet 02 juillet 2012. n.sevenet@bordeaux.unicancer.fr

NEIGE. diagnosis In oncogenetics. Nicolas Sévenet 02 juillet 2012. n.sevenet@bordeaux.unicancer.fr NEIGE g for molecular NExt g generation sequencing diagnosis In oncogenetics Nicolas Sévenet 02 juillet 2012 n.sevenet@bordeaux.unicancer.fr t@b d i f Reports 15 years Next generation sequencing 06/2011

More information

Oncomine Cancer Panel Patient Test Report

Oncomine Cancer Panel Patient Test Report Oncomine Cancer Panel Patient Test Report SUBJECT NFORMATON Pre-Screening Subject No.: Life Technologies Clinical Services Lab 910 Riverside Parkway, Suite 60 West Sacramento, CA 95605 Ph: (888) 734-8588

More information

PREDICT. Comprehensive Hereditary Cancer Risk Assessment

PREDICT. Comprehensive Hereditary Cancer Risk Assessment PREDICT Comprehensive Hereditary Cancer Risk Assessment 1451 NORTHSIDE DRIVE NW SUITE A ATLANTA, GA 30318 (tel) 404.228.5027 (fax) 404.343.0087 LABSOLUTIONS.COM LABSOLUTIONS is pleased to offer its clients

More information

GENETIC COUNSELING FOR BREAST CANCER

GENETIC COUNSELING FOR BREAST CANCER GENETIC COUNSELING FOR BREAST CANCER Anne Heun, MS, CGC Unity Point Health Des Moines Throckmorton Surgical Symposium 2016 Outline High risk genes Moderate risk genes Appropriate referrals or testing candidates

More information

Beyond BRCA the Future is Now

Beyond BRCA the Future is Now Beyond BRCA the Future is Now Richard P. Frieder, MD Medical Director, Intelegene Assistant Clinical Professor Department of Obstetrics and Gynecology David Geffen School of Medicine, UCLA University of

More information

Breast Cancer Risk Assessment and Strategies for Risk Reduction and Prevention

Breast Cancer Risk Assessment and Strategies for Risk Reduction and Prevention Breast Cancer Risk Assessment and Strategies for Risk Reduction and Prevention Mary Cianfrocca, DO, FACP Division Chief of Internal Medicine, Banner MD Anderson Cancer Center Adjunct Associate Professor,

More information

Test Information Sheet

Test Information Sheet Test Information Sheet GeneDx 207 Perry Parkway Gaithersburg, MD 20877 Phone: 888-729-1206 Fax: 301-710-6594 E-mail: wecare@genedx.com www.genedx.com/oncology OncoGene Dx: Breast/Ovarian Cancer Panel Sequence

More information

Big Data Part I: Data-Driven Life Sciences Innovation, Personalized Medicine and Research

Big Data Part I: Data-Driven Life Sciences Innovation, Personalized Medicine and Research Big Data Part I: Data-Driven Life Sciences Innovation, Personalized Medicine and Research December 9, 2014 www.mwe.com Boston Brussels Chicago Düsseldorf Frankfurt Houston London Los Angeles Miami Milan

More information

Gene Panels: The Next Step in Hereditary Cancer Evaluation

Gene Panels: The Next Step in Hereditary Cancer Evaluation Gene Panels: The Net Step in Hereditary Cancer Evaluation Faculty Julia Smith, MD, PhD (Moderator) Clinical Director Cancer Screening Program at the Laura and Isaac Perlmutter Cancer Center at NYU Medical

More information

Test Information Sheet

Test Information Sheet Test Information Sheet GeneDx 207 Perry Parkway Gaithersburg, MD 20877 Phone: 888-729-1206 Fax: 301-710-6594 E-mail: wecare@genedx.com www.genedx.com/oncology OncoGene Dx: Breast/Ovarian Cancer Panel Sequence

More information

A Decision Support Tool to Facilitate Cancer Risk Assessment and Referral for Genetics Services. Kristen Vogel Postula, MS, CGC & Leigh Baumgart, PhD

A Decision Support Tool to Facilitate Cancer Risk Assessment and Referral for Genetics Services. Kristen Vogel Postula, MS, CGC & Leigh Baumgart, PhD A Decision Support Tool to Facilitate Cancer Risk Assessment and Referral for Genetics Services Kristen Vogel Postula, MS, CGC & Leigh Baumgart, PhD Importance of Family History Increasing awareness of

More information

Ion AmpliSeq Technology

Ion AmpliSeq Technology Ion AmpliSeq Technology Dr. Franziska Freund Sr. Sequencing Sales Specialist 26.06.2015 1 The world leader in serving science Ion AmpliSeq Technology: As Simple As PCR Your targets, your genome, your panel

More information

Ovarian Cancer Genetic Testing: Why, When, How?

Ovarian Cancer Genetic Testing: Why, When, How? Ovarian Cancer Genetic Testing: Why, When, How? Jeffrey Dungan, MD Associate Professor Division of Clinical Genetics Department of Obstetrics & Gynecology Northwestern University Feinberg School of Medicine

More information

Cancer Genomics & Precision Medicine in the 21 st Century. Lee J. Helman, MD Scientific Director for Clinical Research CCR, NCI

Cancer Genomics & Precision Medicine in the 21 st Century. Lee J. Helman, MD Scientific Director for Clinical Research CCR, NCI Cancer Genomics & Precision Medicine in the 21 st Century Lee J. Helman, MD Scientific Director for Clinical Research CCR, NCI Outline Define terms Describe vision for how genetic characterization of tumors

More information

Microsatellite Instability (MSI) A New Paradigm in Cancer Treatment. Lynch Syndrome OUTLINE. GI Molecular Pathology

Microsatellite Instability (MSI) A New Paradigm in Cancer Treatment. Lynch Syndrome OUTLINE. GI Molecular Pathology OUTLINE GI Molecular Pathology Microsatellite Instability and Lynch Syndrome GI Cancer Genotyping KRAS Mutations in Colorectal Cancer A. John Iafrate MD-PhD Department of Pathology Massachusetts General

More information

Opportunities and Challenges in Translating Novel Discoveries into Useful Clinical Tests

Opportunities and Challenges in Translating Novel Discoveries into Useful Clinical Tests Opportunities and Challenges in Translating Novel Discoveries into Useful Clinical Tests James H. Doroshow, M.D. NCI Deputy Director for Clinical and Translational Research NCI Workshop: Evidence Needed

More information

TABLE OF CONTENTS. Genoptix Medical Laboratory 2110 Rutherford Road Carlsbad, CA Phone: Fax:

TABLE OF CONTENTS. Genoptix Medical Laboratory 2110 Rutherford Road Carlsbad, CA Phone: Fax: TESTING DIRECTORY TABLE OF CONTENTS Genoptix Medical Laboratory 2110 Rutherford Road Carlsbad, CA 92008 Phone: 760.268.6200 Fax: 760.268.6201 Client Services Phone: 800.755.1605 Fax: 888.755.1604 CLIA

More information

BRCA1/2 and Lynch Syndrome Analyses with CancerNext. POSITIVE: Pathogenic Mutation Detected

BRCA1/2 and Lynch Syndrome Analyses with CancerNext. POSITIVE: Pathogenic Mutation Detected SAMPLE REPORT Ordered By Contact ID:405956 Org ID:249 Physician: Sample Doctor, A Ph:111-222-3333 Client: Sample Organization (00403) Organization Address City CA 99999 US Fx:444-555-6666 Patient Name:

More information

J Clin Oncol 32:2001-2009. 2014 by American Society of Clinical Oncology INTRODUCTION

J Clin Oncol 32:2001-2009. 2014 by American Society of Clinical Oncology INTRODUCTION VOLUME 32 NUMBER 19 JULY 1 2014 JOURNAL OF CLINICAL ONCOLOGY O R I G I N A L R E P O R T Clinical Evaluation of a Multiple-Gene Sequencing Panel for Hereditary Cancer Risk Assessment Allison W. Kurian,

More information

Approaches to Integrating Next Generation Sequencing into the Electronic Health Record

Approaches to Integrating Next Generation Sequencing into the Electronic Health Record AMIA Webinar April 16, 2014 Approaches to Integrating Next Generation Sequencing into the Electronic Health Record Peter Tarczy-Hornoch, University of Washington On behalf of the Clinical Sequencing Exploratory

More information

High-Throughput Mutation Profiling Identifies Frequent Somatic Mutations in Advanced Gastric Adenocarcinoma

High-Throughput Mutation Profiling Identifies Frequent Somatic Mutations in Advanced Gastric Adenocarcinoma High-Throughput Mutation Profiling Identifies Frequent Somatic Mutations in Advanced Gastric Adenocarcinoma The Harvard community has made this article openly available. Please share how this access benefits

More information

Hereditary Breast Cancer Testing. Diagnostic

Hereditary Breast Cancer Testing. Diagnostic Hereditary Cancer Testing Diagnostic New solutions for hereditary breast cancer. Identifying and understanding the genetic contribution to breast cancer allows for individualized disease management and

More information

2014 CPT Code Updates

2014 CPT Code Updates 2014 CPT Code Updates This publication is a summary of The American Medical Association Current Procedural Terminology (CPT) codes published in ARUP's Laboratory Test Directory effective January 1, 2014.

More information

Prevalenza delle mutazioni TMEM127 nel feocromocitoma sporadico

Prevalenza delle mutazioni TMEM127 nel feocromocitoma sporadico Prevalenza delle mutazioni TMEM127 nel feocromocitoma sporadico Giuseppe Opocher Veneto Institute of Oncology and Department of Medical and Surgical Sciences, University of Padova, Italy Sympathetic paraganglia

More information

Genetics and Breast Cancer. Elly Lynch, Senior Genetic Counsellor Manager, Austin Health Clinical Genetics Service

Genetics and Breast Cancer. Elly Lynch, Senior Genetic Counsellor Manager, Austin Health Clinical Genetics Service Genetics and Breast Cancer Elly Lynch, Senior Genetic Counsellor Manager, Austin Health Clinical Genetics Service Overview Background/Our Team What is the difference between sporadic/familial cancer? How

More information

Target enrichment using selector probes. Department of Genetics and Pathology, Uppsala University

Target enrichment using selector probes. Department of Genetics and Pathology, Uppsala University Target enrichment using selector probes Mats Nilsson Department of Genetics and Pathology, Uppsala University Target enrichment using selector probes Even with radically improved sequencing throughput,

More information

Umeå University. Access to the published version may require subscription.

Umeå University. Access to the published version may require subscription. Umeå University This is an accepted version of a paper published in Acta Oncologica. This paper has been peer-reviewed but does not include the final publisher proof-corrections or journal pagination.

More information

MEDICAL POLICY STATEMENT

MEDICAL POLICY STATEMENT MEDICAL POLICY STATEMENT Original Effective Date Next Annual Review Date Last Review / Revision Date 02/24/2015 02/24/2016 04/21/2015 Policy Name Policy Number Genetic Testing, Genetic Screening and Genetic

More information

The Genetics of Early- Onset Breast Cancer. Cecelia Bellcross, Ph.D., M.S.,C.G.C. Department of Human Genetics Emory University School of Medicine

The Genetics of Early- Onset Breast Cancer. Cecelia Bellcross, Ph.D., M.S.,C.G.C. Department of Human Genetics Emory University School of Medicine The Genetics of Early- Onset Breast Cancer Cecelia Bellcross, Ph.D., M.S.,C.G.C. Department of Human Genetics Emory University School of Medicine All cancers are genetic BUT Not all cancers are hereditary

More information

Germline testing for hereditary Cancer Syndromes. Update 2015

Germline testing for hereditary Cancer Syndromes. Update 2015 Germline testing for hereditary Cancer Syndromes Update 2015 Topics to be discussed Case Presentation Standard Indications for testing common syndromes Next Generation Sequencing and panel testing Unique

More information

PATOLOGIA MOLECULAR DEL CANCER GINECOLOGICO. Xavier Matias-Guiu Hospital Universitari Arnau de Vilanova, Universitat de Lleida, IRBLLEIDA.

PATOLOGIA MOLECULAR DEL CANCER GINECOLOGICO. Xavier Matias-Guiu Hospital Universitari Arnau de Vilanova, Universitat de Lleida, IRBLLEIDA. PATOLOGIA MOLECULAR DEL CANCER GINECOLOGICO Xavier Matias-Guiu Hospital Universitari Arnau de Vilanova, Universitat de Lleida, IRBLLEIDA. Carcinoma de Endometrio Cáncer de Ovario Endometrial carcinoma

More information

Frequency of Mutations in Individuals With Breast Cancer Referred for BRCA1 and BRCA2 Testing Using Next-Generation Sequencing With a 25-Gene Panel

Frequency of Mutations in Individuals With Breast Cancer Referred for BRCA1 and BRCA2 Testing Using Next-Generation Sequencing With a 25-Gene Panel Frequency of Mutations in Individuals With Breast Cancer Referred for BRCA1 and BRCA2 Testing Using Next-Generation Sequencing With a 25-Gene Panel Nadine Tung, MD 1,2 ; Chiara Battelli, MD 1 ; Brian Allen,

More information

Hereditary Breast Cancer Testing. clinician guide

Hereditary Breast Cancer Testing. clinician guide Hereditary Breast Cancer Testing clinician guide Ambry s test offerings are designed to provide flexible, comprehensive options tailored to your patients personal and family histories. New Solutions for

More information

BRCA and Other Genetic Abnormalities

BRCA and Other Genetic Abnormalities Genes and Cancer BRCA and Other Genetic Abnormalities Anne Heun, MS, CGC Certified Genetic Counselor John Stoddard Cancer Center All cancer is GENETIC Tumor suppressor gene: a.k.a. anti-oncogene Important

More information

Breast and Ovarian Cancer

Breast and Ovarian Cancer Breast and Ovarian Cancer Hereditary Breast and Ovarian Cancer A Guide for Clinicians KNOWING WHAT TO LOOK FOR KNOWING WHERE TO LOOK AND KNOWING WHAT IT MEANS Hereditary Breast and Ovarian Cancer Panel

More information

Public-Private Partnerships in early phase clinical research: Spurring access to innovative therapeutics

Public-Private Partnerships in early phase clinical research: Spurring access to innovative therapeutics EPAAC WP8 Research Forum - 2 July, Sofitel Hotel Europe, Brussels Public-Private Partnerships in early phase clinical research: Spurring access to innovative therapeutics JY Blay, Past President EORTC

More information

Molecular Human Genetics. Cancer, Tumor suppressor genes, Oncogenes

Molecular Human Genetics. Cancer, Tumor suppressor genes, Oncogenes Youtube ARCC http://www.youtube.com/watch?v=3pobqrfz0no It's Our Time - American Association for Cancer Research (AACR) Molecular Human Genetics Cancer, Tumor suppressor genes, Oncogenes Hum 2014/15 1

More information

6/10/2015. Hereditary Predisposition for Breast Cancer: Looking at BRCA1/BRCA2 Testing & Beyond. Hereditary Cancers. BRCA1 and BRCA2 Review

6/10/2015. Hereditary Predisposition for Breast Cancer: Looking at BRCA1/BRCA2 Testing & Beyond. Hereditary Cancers. BRCA1 and BRCA2 Review Hereditary Predisposition for Breast Cancer: Looking at BRCA1/BRCA2 Testing & Beyond Arturo Anguiano MD, FACMG International Medical Director, Medical Affairs Vice Chairman, Genetics; Medical Director,

More information

Avances en la Patología Molecular del Cáncer de Endometrio

Avances en la Patología Molecular del Cáncer de Endometrio CURSO DE PATOLOGÍA GINECOLÓGICA II Actualizaciones en patología cervical y endometrial Avances en la Patología Molecular del Cáncer de Endometrio José Palacios Hospital Universitario Ramón y Cajal. Madrid

More information

Evalua&ng tumor exome sequencing in the oncology clinic:

Evalua&ng tumor exome sequencing in the oncology clinic: Evalua&ng tumor exome sequencing in the oncology clinic: Lessons from the BASIC3 study GBM Cancer Risk? A Clinical Sequencing Exploratory Research (CSER) project Supported by NHGRI/NCI 1U01HG006485 ISMB2014

More information

Colon Cancer Syndromes. Robin B. Mendelsohn MD Memorial Sloan Kettering Cancer Center Department of Medicine Gastroenterology and Nutrition Service

Colon Cancer Syndromes. Robin B. Mendelsohn MD Memorial Sloan Kettering Cancer Center Department of Medicine Gastroenterology and Nutrition Service Colon Cancer Syndromes Robin B. Mendelsohn MD Memorial Sloan Kettering Cancer Center Department of Medicine Gastroenterology and Nutrition Service Background: Etiology of Colorectal Cancer (CRC) Sporadic:

More information

Common Cancers & Hereditary Syndromes

Common Cancers & Hereditary Syndromes Common Cancers & Hereditary Syndromes Elizabeth Hoodfar, MS, LCGC Regional Cancer Genetics Coordinator Kaiser Permanente Northern California Detect clinical characteristics of hereditary cancer syndromes.

More information

CALL FOR PARTNERSHIP MULTIPLI PROGRAM

CALL FOR PARTNERSHIP MULTIPLI PROGRAM CALL FOR PARTNERSHIP MULTIPLI PROGRAM I. Introduction The MULTIPLI program, coordinated by Inserm (the French National Institute of Health and Medical Research) and the Cancer Institute of the French National

More information

Factsheet Renal Cancer Panel. minimum DNA (µg) minimum EDTA blood (ml) minimum filtercards (pcs)

Factsheet Renal Cancer Panel. minimum DNA (µg) minimum EDTA blood (ml) minimum filtercards (pcs) Renal cancer panel Centogene ID: 5235 Gene(s) name (OMIM, HGNC): Gene Renal Cancer Panel EPCAM, FH, FLCN, HNF1A, HNF1B, MET, MITF, MLH1, MSH2, MSH6, PMS1, PMS2, PTEN, SDHB, SDHD, TSC1, TSC2, VHL, WT1 1.

More information

Genomic instability in cancers and cancer predispositions. Popova Tatiana Inserm U830 Institut Curie

Genomic instability in cancers and cancer predispositions. Popova Tatiana Inserm U830 Institut Curie Genomic instability in cancers and cancer predispositions Popova Tatiana Inserm U830 Institut Curie Time-scale in a tumor genome discovery Bovery HYP Cancer genome Knudson 2 hit HYP Tumor DNA has transforming

More information

Submitted 12 September 2014; accepted 12 September 2014; advance online publication 13 November 2014. doi:10.1038/gim.2014.147. Genetics in medicine

Submitted 12 September 2014; accepted 12 September 2014; advance online publication 13 November 2014. doi:10.1038/gim.2014.147. Genetics in medicine American College of Medical Genetics and Genomics ACMG Practice Guidelines A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors:

More information

Progress and Prospects in Ovarian Cancer Screening and Prevention

Progress and Prospects in Ovarian Cancer Screening and Prevention Progress and Prospects in Ovarian Cancer Screening and Prevention Rebecca Stone, MD MS Assistant Professor Kelly Gynecologic Oncology Service The Johns Hopkins Hospital 1 No Disclosures 4/12/2016 2 Ovarian

More information

Inherited breast cancer Inherited colon cancer Other inherited cancer predispositions

Inherited breast cancer Inherited colon cancer Other inherited cancer predispositions 13.40-14.00 Inherited breast cancer 14.00-14.20 Inherited colon cancer 14.20-14.40 Other inherited cancer predispositions Dr Anne De Leener Centre de Génétique Humaine 1. INHERITED BREAST CANCER Introduction

More information

Cardio Gene panel experience. Jan Jongbloed Laboratory Specialist Clinical Genetics Genome Diagnostics Department of Genetics UMCG Groningen

Cardio Gene panel experience. Jan Jongbloed Laboratory Specialist Clinical Genetics Genome Diagnostics Department of Genetics UMCG Groningen Cardio Gene panel experience Jan Jongbloed Laboratory Specialist Clinical Genetics Genome Diagnostics UMCG Groningen CardioGenetics: Rowida Almomani Ludolf Boven Anne Herkert Yvonne Hoedemaekers Irene

More information

WHITE PAPER SEPT 2015

WHITE PAPER SEPT 2015 WHITE PAPER SEPT 2015 LIQUID BIOPSY FOR THE DETECTION AND MONITORING OF CANCER: ANALYSIS OF 96 HOTSPOT MUTATIONS VIA PLASMA DERIVED CIRCULATING TUMOR DNA PATHWAY GENOMICS CANCER AND SOMATIC MUTATIONS The

More information

Molecular Pathology/Molecular Diagnostics/Genetic Testing

Molecular Pathology/Molecular Diagnostics/Genetic Testing Policy Number GEN01252012RP Approved By UnitedHealthcare Medicare Reimbursement Policy Committee Current Approval Date 01/28/2015 IMPORTANT NOTE ABOUT THIS REIMBURSEMENT POLICY This policy is applicable

More information

Examples of The Cancer Genome Atlas (TCGA) Analyses in GenePool

Examples of The Cancer Genome Atlas (TCGA) Analyses in GenePool Examples of The Cancer Genome Atlas (TCGA) Analyses in 1. RNA-Seq 2. mirna-seq 3. Protein Expression 4. Somatic Mutations 5. Copy Number 6. DNA Methylation RNA-Seq All primary tumor samples (1,097 of 1,218)

More information

July 14, 2014. Centers for Medicare & Medicaid Services 7500 Security Boulevard Baltimore, MD 21244

July 14, 2014. Centers for Medicare & Medicaid Services 7500 Security Boulevard Baltimore, MD 21244 ASCP s Statements before the Centers for Medicare and Medicaid Services Regarding Recommendations for Crosswalking/Gapfilling New CPT s for the CLFS for CY 2015 and the Revaluation of the Clinical Laboratory

More information

Name of Policy: Genetic Testing for Inherited Cancer Predisposition and/or Pharmacogenetics related to Cancer Treatment

Name of Policy: Genetic Testing for Inherited Cancer Predisposition and/or Pharmacogenetics related to Cancer Treatment Name of Policy: Genetic Testing for Inherited Cancer Predisposition and/or Pharmacogenetics related to Cancer Treatment Policy #: 133 Latest Review Date: April 2015 Category: Laboratory Policy Grade: D

More information

The Role of Next Generation Sequencing in Solid Tumor Mutation Testing

The Role of Next Generation Sequencing in Solid Tumor Mutation Testing The Role of Next Generation Sequencing in Solid Tumor Mutation Testing Allie H. Grossmann MD PhD Department of Pathology, University of Utah Division of Anatomic Pathology & Oncology, ARUP Laboratories

More information

Next Generation Sequencing in Early-Phase Clinical Trials in Cancer Filip Janku

Next Generation Sequencing in Early-Phase Clinical Trials in Cancer Filip Janku 11 th International Congress on Targeted Anticancer Therapies Paris March 4-6, 2013 Next Generation Sequencing in Early-Phase Clinical Trials in Cancer Filip Janku Investigational Cancer Therapeutics (Phase

More information

Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer

Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer /, Vol. 7, No. 7 Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer Po-Han Lin 1,2, Wen-Hung Kuo 3, Ai-Chu Huang 2, Yen-Shen Lu 4, Ching-Hung Lin 4, Sung-Hsin

More information

Introducing Dorevitch s Genomic Diagnostics

Introducing Dorevitch s Genomic Diagnostics Genetic Testing Introducing Dorevitch s Genomic Diagnostics As one of Australia s longest running and nationally coordinated DNA testing organisations, Dorevitch s Genomic Diagnostics perform specialised

More information

Genomic Medicine The Future of Cancer Care. Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America

Genomic Medicine The Future of Cancer Care. Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America Genomic Medicine The Future of Cancer Care Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America Personalized Medicine Personalized health care is a broad term for interventions

More information

ACG Clinical Guideline: Genetic Testing and Management of Hereditary Gastrointestinal Cancer Syndromes

ACG Clinical Guideline: Genetic Testing and Management of Hereditary Gastrointestinal Cancer Syndromes PRACTICE GUIDELINES nature publishing group 223 CME ACG Clinical Guideline: Genetic Testing and Management of Hereditary Gastrointestinal Cancer Syndromes Sapna Sy nga l, MD, M PH, FAC G 1, 2, 3, R and

More information

Towards new classifications and individualised treatment for cancer patients

Towards new classifications and individualised treatment for cancer patients Towards new classifications and individualised treatment for cancer patients Professor Thomas TURSZ General Director Institut Gustave Roussy Villejuif Paris - France Workshop Chemores Milano January 21

More information

Metastatic Hereditary Breast Cancer: What s New? Melinda Telli, M.D. Assistant Professor of Medicine Stanford University School of Medicine

Metastatic Hereditary Breast Cancer: What s New? Melinda Telli, M.D. Assistant Professor of Medicine Stanford University School of Medicine Metastatic Hereditary Breast Cancer: What s New? Melinda Telli, M.D. Assistant Professor of Medicine Stanford University School of Medicine Outline Treatment principles in metastatic breast cancer Update

More information

RUO Molecular Probes For in situ hybridization

RUO Molecular Probes For in situ hybridization RUO Molecular Probes For in situ hybridization Molecular Probes The RUO (Research Use Only) molecular probes from Roche deliver highly specific staining on our fully automated platforms. Utilizing a unique

More information

Molecular pathology of thyroid cancers

Molecular pathology of thyroid cancers Molecular pathology of thyroid cancers Peter Lakatos 1st Department of Medicine Semmelweis University Thyroid nodules 4-7% of population with palpable nodules More frequent in women Incidence increasing

More information

CANCER RESEARCH UK STRATIFIED MEDICINE PROGRAMME IAN WALKER PHD, MBA HEAD OF STRATIFIED MEDICINE

CANCER RESEARCH UK STRATIFIED MEDICINE PROGRAMME IAN WALKER PHD, MBA HEAD OF STRATIFIED MEDICINE CANCER RESEARCH UK STRATIFIED MEDICINE PROGRAMME IAN WALKER PHD, MBA HEAD OF STRATIFIED MEDICINE Agenda Introduction to Cancer Research UK CRUK Stratified Medicine Programme Key Challenges and Lessons

More information

Disclosures. Personalized Meds from the molecular onco-pathology s perspective

Disclosures. Personalized Meds from the molecular onco-pathology s perspective 1 FIGON DMD Symposium From Protocol towards Personalized Tailored Therapy Ede, October 6th 2015 Personalized Meds from the molecular onco-pathology s perspective Diagnostic in Pathology in 2015-2020 Molecular

More information

Chronic Lymphocytic Leukemia - Disease and Current Therapies from a Medical Perspective

Chronic Lymphocytic Leukemia - Disease and Current Therapies from a Medical Perspective Chronic Lymphocytic Leukemia - Disease and Current Therapies from a Medical Perspective C. Reinhardt Medical Clinic I, Hematology/Oncology CECAD, Research Area C Clinical and Molecular Oncology CLL - an

More information

Immunophenotyping of hereditary breast cancer

Immunophenotyping of hereditary breast cancer Immunophenotyping of hereditary breast cancer Petra van der Groep Cover design: P. van der Groep Lay-out: Gildeprint Drukkerijen - Enschede, The Netherlands Printed by: Gildeprint Drukkerijen - Enschede,

More information

Application of Molecular Diagnosis: Present and Future

Application of Molecular Diagnosis: Present and Future Application of Molecular Diagnosis: Present and Future Dong Jun Lim, MD., PhD. Associate Professor Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary s Hospital,

More information

The Future of Clinical Chemistry and Laboratory Medicine, The Diagnostics Industry View

The Future of Clinical Chemistry and Laboratory Medicine, The Diagnostics Industry View The Future of Clinical Chemistry and Laboratory Medicine, The Diagnostics Industry View Peng Yin, M.D., Ph.D., Director, Global Scientific Affairs Abbott Diagnostic Division (ADD) Agenda Lack of perceived

More information

Epithelial Ovarian Cancer

Epithelial Ovarian Cancer Epithelial Ovarian Cancer Fred Ueland, MD University of Kentucky Gynecologic Oncology Risk Factors Incessant ovulation Early menarche, late menopause, low parity Family history Acquired genetic mutations

More information

Name of Policy: Genetic Testing for Inherited Cancer Predisposition and/or Pharmacogenetics related to Cancer Treatment

Name of Policy: Genetic Testing for Inherited Cancer Predisposition and/or Pharmacogenetics related to Cancer Treatment Name of Policy: Genetic Testing for Inherited Cancer Predisposition and/or Pharmacogenetics related to Cancer Treatment Policy #: 133 Latest Review Date: April 2015 Category: Laboratory Policy Grade: D

More information

Clinical Use of Molecular Diagnos@cs in the Treatment of Lung Cancer

Clinical Use of Molecular Diagnos@cs in the Treatment of Lung Cancer Clinical Use of Molecular Diagnos@cs in the Treatment of Lung Cancer Tianhong Tina Li, MD, PhD (thli@ucdavis.edu) Associate Professor of Clinical Medicine, School of Medicine Disclosures Grants/Research

More information

Stato dell arte e prospettive delle terapie a bersaglio molecolare nel carcinoma polmonare

Stato dell arte e prospettive delle terapie a bersaglio molecolare nel carcinoma polmonare Stato dell arte e prospettive delle terapie a bersaglio molecolare nel carcinoma polmonare Giorgio V. Scagliotti Università di Torino Dipartimento di scienze cliniche & biologiche giorgio.scagliotti@unito.it

More information

GeneQuery Human Epithelial Cell Biology qpcr Array Kit (GQH-EPI) Catalog #GK005

GeneQuery Human Epithelial Cell Biology qpcr Array Kit (GQH-EPI) Catalog #GK005 GeneQuery Human Epithelial Cell Biology qpcr Array Kit (GQH-EPI) Catalog #GK005 Product Description ScienCell's GeneQuery Human Epithelial Cell Biology qpcr array kit (GQH-EPI) is designed to facilitate

More information

Een behandeling op maat voor iedere patient: wat betekent dat in de praktijk? Emile Voest

Een behandeling op maat voor iedere patient: wat betekent dat in de praktijk? Emile Voest Een behandeling op maat voor iedere patient: wat betekent dat in de praktijk? Emile Voest Need for personalised cancer treatment Scenario: patient with metastasized colorectal cancer Doctor suggests treatment

More information

Hereditary Colon Cancer

Hereditary Colon Cancer Hereditary Colon Cancer Eric D. Libby, MD Winchester Hospital Family History of Colon Cancer Most colon cancer occurs in patients without a family history 70-80% is sporadic Only 20-30% of cancer patient

More information

Molecular Diagnosis of Gastrointestinal Tumors

Molecular Diagnosis of Gastrointestinal Tumors Molecular Diagnosis of Gastrointestinal Tumors Zoltan Szentirmay National Institute of Oncology Center of Surgical and Molecular Tumor Pathology EEA and Norwegian Financial Mechanisms in Hungary, Development

More information

The Next Generation of Genomic Testing: Billing and Reimbursement in the Genomic Era

The Next Generation of Genomic Testing: Billing and Reimbursement in the Genomic Era The Next Generation of Genomic Testing: Billing and Reimbursement in the Genomic Era Co-Moderators: Jerry Feldman, MD, PhD, FACMG Wayne State University School of Medicine Detroit Medical Center University

More information

Stage III & IV colon and rectal cancers share a similar genetic profile: a review of the Oregon Colorectal Cancer Registry

Stage III & IV colon and rectal cancers share a similar genetic profile: a review of the Oregon Colorectal Cancer Registry The American Journal of Surgery (2013) 205, 608-612 North Pacific Surgical Association Stage III & IV colon and rectal cancers share a similar genetic profile: a review of the Oregon Colorectal Cancer

More information

Risk stratification for colorectal cancer especially: the difference between sporadic disease and polyposis syndromes. Dr. med. Henrik Csaba Horváth

Risk stratification for colorectal cancer especially: the difference between sporadic disease and polyposis syndromes. Dr. med. Henrik Csaba Horváth Risk stratification for colorectal cancer especially: the difference between sporadic disease and polyposis syndromes Dr. med. Henrik Csaba Horváth Why is risk stratification for colorectal cancer (CRC)

More information

COLON CANCER: PAST, PRESENT, AND FUTURE AND FAMILIAL SYNDROMES. Eun Lee, MD, Professor & Director of Anatomic Pathology

COLON CANCER: PAST, PRESENT, AND FUTURE AND FAMILIAL SYNDROMES. Eun Lee, MD, Professor & Director of Anatomic Pathology COLON CANCER: PAST, PRESENT, AND FUTURE AND FAMILIAL SYNDROMES Eun Lee, MD, Professor & Director of Anatomic Pathology MCC Affiliate Network Meeting Etiology for colon cancer Past, Present, and Future

More information

Genomic Clinical Trials: NCI Initiatives

Genomic Clinical Trials: NCI Initiatives Genomic Clinical Trials: NCI Initiatives James H. Doroshow, M.D. Deputy Director for Clinical and Translational Research National Cancer Institute National Cancer Advisory Board Washington, DC December

More information

Genetics of Pancreatic Cancer

Genetics of Pancreatic Cancer Genetics of Pancreatic Cancer Gloria M. Petersen, Ph.D. Mayo Clinic Rochester, Minnesota Pancreatic Cancer Action Network Bloomington, MN Topics Is family history a risk factor for pancreatic cancer? Why

More information

Molecular Stratification of Cancer in the

Molecular Stratification of Cancer in the Molecular Stratification of Cancer in the Clinical Setting David Gonzalez de Castro Molecular Diagnostics NHS FT and The Institute of Cancer Research, London, UK 1 2 The complexity of human cancer genomes

More information